Fremont, CA, United States of America

Misty Piagentini

This inventor holds 1 USPTO granted patent. Top assignee: Kosan Biosciences Incorporated. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Misty Piagentini. Retrieved from https://idiyas.com/inventor/misty-piagentini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Misty Piagentini

Introduction

Misty Piagentini is a notable inventor based in Fremont, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antiproliferative agents. Her work has garnered attention for its potential applications in medical treatments.

Latest Patents

Misty holds a patent for "2-Desmethyl ansamycin compounds." This patent describes 2-desmethyl ansamycins that possess a specific structure, where R, R, R, R, R, and R are defined within the patent. These compounds are recognized for their usefulness as antiproliferative agents, showcasing her innovative approach to addressing health challenges.

Career Highlights

Misty is currently associated with Kosan Biosciences Incorporated, where she continues to push the boundaries of scientific research. Her dedication to innovation in biotechnology has positioned her as a key figure in her field.

Collaborations

Throughout her career, Misty has collaborated with esteemed colleagues, including Zong-Qiang Tian and Robert G McDaniel. These partnerships have further enriched her research and contributed to her success as an inventor.

Conclusion

Misty Piagentini's work exemplifies the spirit of innovation in biotechnology. Her contributions, particularly in the realm of antiproliferative agents, highlight her commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…